| Study name |
Mistletoe as Complementary Treatment in Patients With Advanced Non‐Small‐Cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination: Randomized Phase II Study |
| Methods |
Single center study, randomized phase II, open label, active control |
| Participants |
Pats with NSCLC |
| Interventions |
Iscador in combination with Gemcitabine/Carboplatin vs. Gemcitabine/Carboplatin alone |
| Outcomes |
QOL, toxicity profile of the chemotherapy treatment, time to tumor progression (TTP), survival, safety profile of mistletoe extracts |
| Starting date |
April 2007 |
| Contact information |
http://clinicaltrials.gov/ct2/show/NCT00516022?term=mistletoe&rank=1 |
| Notes |
|
